Page 2 - Bvxv News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bvxv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bvxv Today - Breaking & Trending Today
StockNews.com initiated coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a research note published on Friday morning. The firm issued a hold rating on the stock. BiondVax Pharmaceuticals Trading Up 3.8 % Shares of BVXV opened at $1.36 on Friday. BiondVax Pharmaceuticals has a 12 month low of $1.25 and a 12 […] ....
StockNews.com assumed coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a report issued on Thursday. The brokerage issued a hold rating on the stock. BiondVax Pharmaceuticals Stock Performance BiondVax Pharmaceuticals stock opened at $1.31 on Thursday. The stock’s 50 day moving average price is $1.37 and its 200 day moving average price […] ....
StockNews.com assumed coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a research report sent to investors on Thursday morning. The brokerage issued a hold rating on the stock. BiondVax Pharmaceuticals Stock Down 3.3 % Shares of BVXV stock opened at $1.31 on Thursday. The stock has a 50-day simple moving average of […] ....
BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV – Get Free Report) was the recipient of a large increase in short interest in August. As of August 15th, there was short interest totalling 4,900 shares, an increase of 36.1% from the July 31st total of 3,600 shares. Based on an average daily volume of 155,000 shares, the days-to-cover ratio […] ....
StockNews.com assumed coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a report issued on Wednesday. The brokerage issued a hold rating on the stock. BiondVax Pharmaceuticals Price Performance Shares of BVXV opened at $1.32 on Wednesday. BiondVax Pharmaceuticals has a 12-month low of $1.25 and a 12-month high of $11.80. The firm […] ....